Nuria Nieto-Nicolau

Nuria Nieto-Nicolau

Auto-generated profile, based on publicly available information

Nuria Nieto-Nicolau

Barcelona Tissue Bank (BTB), Banc de Sang i Teixits (BST), Barcelona, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
NNN Nieto-Nicolau
N Nieto-Nicolau
PLP López-Chicón
P López-Chicón
OFO Fariñas
O Fariñas
Sara BolívarSara Bolívar
Sara Bolívar
EUE Udina
E Udina
AVA Vilarrodona
A Vilarrodona

1 January 2016 in Stem Cells International
Verified
Journal Article
Open access
PDF file
NNNuria Nieto-Nicolau
Nuria Nieto-Nicolau
EMEva M. Martínez-Conesa
Eva M. Martínez-Conesa
Ricardo Casaroli-MaranoRicardo Casaroli-Marano
Ricardo Casaroli-Marano
Limbal stem cells (LSC) are the progenitor cells that maintain the transparency of the cornea. Limbal stem cell deficiency (LSCD) leads to corneal opacity, inflammation, scarring, and blindness. A clinical approach to treat this condition consists in LSC transplantation (LSCT) after ex vivo expansion of LSC. In unilateral LSCD, an autologous transplant is possible, but cases of bilateral LSCD require allogenic LSCT. Cadaveric donors represent the most important source of LSC allografts for treatment of bilateral LSCD when living relative donors are not available. To evaluate the suitability of aged cadaveric donors for LSCT, we compared three pools of LSC from donors of different ages (75 years). We evaluated graft quality in terms of percent of p63‐positive (p63+) cells by immunofluorescence, colony forming efficiency, and mRNA and protein expression of p63, PAX6, Wnt7a, E‐cadherin, and cytokeratin (CK) 12, CK3, and CK19. The results showed that LSC cultures from aged donors can express ≥3% of p63+ cells—considered as the minimum value for predicting favorable clinical outcomes after LSCT—suggesting that these cells could be a suitable source of LSC for transplantation. Our results also indicate the need to evaluate LSC graft quality criteria for each donor.

15 February 2022 in Biopreservation and Biobanking
Verified
Journal Article
Closed access
NNNuria Nieto-Nicolau
Nuria Nieto-Nicolau
PLPatricia López-Chicón
Patricia López-Chicón
CTCarlos Torrico
Carlos Torrico
SBSara Bolívar
Sara Bolívar
ECEstefania Contreras-Carreton
Estefania Contreras-Carreton
AVAnna Vilarrodona
Anna Vilarrodona
Background: Decellularized human nerves overcome the limitations of the current treatments for large peripheral nerve injuries. However, the use of decellularized nerves requires an “off-the-shelf” availability for useful and actual clinical application. In this study, we addressed the preservation of the native and decellularized human nerve matrix in an integrative approach for tissue scaffold production. Materials and Methods: For native nerve matrix preservation analysis, we used histological examination and immunofluorescence to examine the structure, biomechanical assays to evaluate the tensile strength and Young's modulus, and analyzed the extracellular matrix (ECM) composition using enzyme-linked immunosorbent assay (ELISA) and biochemical assays for laminin, collagen and sulfated glycosaminoglycans (sGAG). After decellularization, nuclear remnants and DNA content were evaluated using 4′,6-diamidino-2-phenylindole (DAPI) staining and the picogreen quantification assay, as well as immunofluorescence or ELISA for cell rests (S100 protein and myelin staining) evaluation. Decellularized cryopreserved scaffolds were assayed for biomechanics, ECM composition, and structural maintenance. Cytotoxicity assays were performed to evaluate the biocompatibility of the nerve matrix extracts after cryopreservation. Results: We compared different strategies for native nerve storage and found that preservation up to 7 days at 4°C in Roswell Park Memorial Institute medium maintained biomechanical properties, such as Young's modulus and tensile strength, along with the structure and ECM composition, regarding laminin, collagen, and sGAG. After a successful decellularization process, that eliminated cell remnants, nerve scaffolds were frozen in an “in house” formulated cryoprotectant, using an automatic controlled rate freezer. Nerve structure, ECM composition, and biomechanical properties were maintained before and after the freezing process in comparison with native nerves. The extracts of the nerve scaffolds after thawing were not cytotoxic and the freezing process sustained good viability in 3T3 cells (graphical abstract). Conclusion: Since our approach facilitates transport, storage, and provide a ready-to-use alternative, it could be used in a clinical application for the treatment of long-gap peripheral nerve injuries in regenerative medicine.

2 March 2019
Verified
Book Chapter
Closed access
PDF file
Ricardo Casaroli-MaranoRicardo Casaroli-Marano
Ricardo Casaroli-Marano
NNNúria Nieto-Nicolau
Núria Nieto-Nicolau
RTRaquel A. Martínez-García de la Torre
Raquel A. Martínez-García de la Torre